Presentation
13 March 2024 IDH targeted fluorescence guided surgery in low grade gliomas
Author Affiliations +
Abstract
Gross total resection of low grade gliomas is associated with prolonged time to malignant transformation and ultimately overall survival. Unfortunately, rates of gross total resection are reported to be as low as 20-40%. Current strategies in fluorescence guidance are lacking for low grade gliomas and represent an unmet need. We have developed a novel fluorescence exploiting the highly conserved IDH mutant protein that is present in >80% of these tumors. To date there are well described small molecule IDH mutant inhibitors in clinical trial. We describe the development of small molecule fluorescent inhibitors of the IDH mutant protein and their potential applications in surgery for LGG.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Linton Evans, Lei G. Wang, Augustino V. Scorzo, Rendall Strawbridge, Scott C. Davis, and Summer Gibbs "IDH targeted fluorescence guided surgery in low grade gliomas", Proc. SPIE PC12825, Molecular-Guided Surgery: Molecules, Devices, and Applications X, PC128250S (13 March 2024); https://doi.org/10.1117/12.3023422
Advertisement
Advertisement
KEYWORDS
Fluorescence

Surgery

Target designation

Tumors

Resection

Blood brain barrier

Molecules

Back to Top